Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial-Reference-Cited by-同舟云学术

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

Published:2018-02 Issue:2 Volume:19 Page:181-193
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Amaria Rodabe N,Prieto Peter A,Tetzlaff Michael T,Reuben Alexandre,Andrews Miles C,Ross Merrick I,Glitza Isabella C,Cormier Janice,Hwu Wen-Jen,Tawbi Hussein A,Patel Sapna P,Lee Jeffrey E,Gershenwald Jeffrey E,Spencer Christine N,Gopalakrishnan Vancheswaran,Bassett Roland,Simpson Lauren,Mouton Rosalind,Hudgens Courtney W,Zhao Li,Zhu Haifeng,Cooper Zachary A,Wani Khalida,Lazar Alexander,Hwu Patrick,Diab Adi,Wong Michael K,McQuade Jennifer L,Royal Richard,Lucci Anthony,Burton Elizabeth M,Reddy Sangeetha,Sharma Padmanee,Allison James,Futreal Phillip A,Woodman Scott E,Davies Michael A,Wargo Jennifer A

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

2. Interferon alpha for the adjuvant treatment of cutaneous melanoma;Mocellin;Cochrane Database Syst Rev,2013

3. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy;Eggermont;N Engl J Med,2016

4. Phase II trial of neoadjuvant temozolomide in resectable melanoma patients;Shah;Ann Oncol,2010

5. Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses;Moschos;J Clin Oncol,2006

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatment;European Journal of Surgical Oncology;2024-02

2. Neoadjuvant therapy for resectable melanoma;Clinical & Experimental Metastasis;2024-01-28

3. Neoadjuvante Therapie des Melanoms;best practice onkologie;2024-01-05

4. Preoperative therapy in melanoma: Evolving perspectives in clinical trials;Critical Reviews in Oncology/Hematology;2024-01

5. Systemic Therapy for Melanoma: ASCO Guideline Update;Journal of Clinical Oncology;2023-10-20